Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 1

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
146,502  
     147,119 
  
    Total Liabilities 
     1,948,978  
     1,804,339 
  
    Commitments and Contingencies (Note 11) 

    SHAREHOLDERS’ EQUITY: 

    Series A Preferred Stock, $0.0001 par value, 1,000,000 shares authorized; 76,480 and 76,480 issued and outstanding as of March 31, 2025 and December 31, 2024, respectively (Note 6) 
     9,567,439  
     9,567,439 
  
    Common Stock, $0.0001 par value, 150,000,000 shares authorized; 1,472,891 and 566,908  issued and outstanding as of March 31, 2025 and December 31, 2024, respectively(1) (Note 6) 
     147  
     57 
  
    Additional Paid-in Capital(1) 
     36,821,588  
     34,860,590 
  
    Accumulated Other Comprehensive Income 
     125,567  
     135,471 
  
    Accumulated Deficit 
     (42,404,506) 
     (40,527,957)
  
    60P Shareholders’ Equity: 
     4,110,235  
     4,035,600 
  
    Noncontrolling Interest 
     (81,346) 
     (80,594)
  
    Total Shareholders’ Equity 
     4,028,889  
     3,955,006 
  
    Total Liabilities and Shareholders’ Equity 
    $5,977,867  
    $5,759,345 

(1)Prior periods presented have been adjusted to reflect the
1:12 reverse stock split on August 12, 2024 and the 1:5 reverse stock split on February 24, 2025.

The accompanying notes are an integral part of these unaudited
consolidated condensed financial statements.

1

60 DEGREES PHARMACEUTICALS, INC.

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE (LOSS) INCOME (UNAUDITED)

    For The Three Months Ended March 31,